 | • レポートコード：GIR201114484 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、マールブルクウイルス感染症の世界市場を調査対象にし、マールブルクウイルス感染症の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Arno Therapeutics Inc、NanoViricides Inc、Emergent BioSolutions Inc、BioCryst Pharmaceuticals Inc、Johnson & Johnson、Eisai Co Ltd、Rodos BioTarget GmbH、Integrated BioTherapeutics Inc、Fab'entech SA、Profectus BioSciences Inc、Sarepta Therapeutics Inc、Theravectys SA ・企業別売上、市場シェア ・マールブルクウイルス感染症の地域別市場分析 ・マールブルクウイルス感染症の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・マールブルクウイルス感染症のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・マールブルクウイルス感染症のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・マールブルクウイルス感染症の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・マールブルクウイルス感染症の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・マールブルクウイルス感染症の種類別市場規模2015-2020：エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他 ・マールブルクウイルス感染症の用途別市場規模2015-2020：病院、クリニック、その他 ・マールブルクウイルス感染症の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Marburgvirus Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Marburgvirus Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Marburgvirus Infection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Marburgvirus Infection market has been segmented into:
Eritoran Tetrasodium
AR-12
ARD-5
AVI-7288
Others
By Application, Marburgvirus Infection has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Marburgvirus Infection market presented in the report. This section sheds light on the sales growth of different regional and country-level Marburgvirus Infection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Marburgvirus Infection market.
The report offers in-depth assessment of the growth and other aspects of the Marburgvirus Infection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Marburgvirus Infection Market Share Analysis
Marburgvirus Infection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Marburgvirus Infection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Marburgvirus Infection sales, revenue and market share for each player covered in this report.
The major players covered in Marburgvirus Infection are:
Arno Therapeutics Inc
NanoViricides Inc
Emergent BioSolutions Inc
BioCryst Pharmaceuticals Inc
Johnson & Johnson
Eisai Co Ltd
Rodos BioTarget GmbH
Integrated BioTherapeutics Inc
Fab’entech SA
Profectus BioSciences Inc
Sarepta Therapeutics Inc
Theravectys SA
Table of Contents
1 Marburgvirus Infection Market Overview
1.1 Product Overview and Scope of Marburgvirus Infection
1.2 Classification of Marburgvirus Infection by Type
1.2.1 Global Marburgvirus Infection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Marburgvirus Infection Revenue Market Share by Type in 2019
1.2.3 Eritoran Tetrasodium
1.2.4 AR-12
1.2.5 ARD-5
1.2.6 AVI-7288
1.2.7 Others
1.3 Global Marburgvirus Infection Market by Application
1.3.1 Overview: Global Marburgvirus Infection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Marburgvirus Infection Market by Regions
1.4.1 Global Marburgvirus Infection Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Marburgvirus Infection (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Marburgvirus Infection Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Marburgvirus Infection Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Marburgvirus Infection Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Marburgvirus Infection Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Marburgvirus Infection Status and Prospect (2015-2025)
2 Company Profiles
2.1 Arno Therapeutics Inc
2.1.1 Arno Therapeutics Inc Details
2.1.2 Arno Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Arno Therapeutics Inc SWOT Analysis
2.1.4 Arno Therapeutics Inc Product and Services
2.1.5 Arno Therapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.2 NanoViricides Inc
2.2.1 NanoViricides Inc Details
2.2.2 NanoViricides Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 NanoViricides Inc SWOT Analysis
2.2.4 NanoViricides Inc Product and Services
2.2.5 NanoViricides Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.3 Emergent BioSolutions Inc
2.3.1 Emergent BioSolutions Inc Details
2.3.2 Emergent BioSolutions Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Emergent BioSolutions Inc SWOT Analysis
2.3.4 Emergent BioSolutions Inc Product and Services
2.3.5 Emergent BioSolutions Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioCryst Pharmaceuticals Inc
2.4.1 BioCryst Pharmaceuticals Inc Details
2.4.2 BioCryst Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioCryst Pharmaceuticals Inc SWOT Analysis
2.4.4 BioCryst Pharmaceuticals Inc Product and Services
2.4.5 BioCryst Pharmaceuticals Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eisai Co Ltd
2.6.1 Eisai Co Ltd Details
2.6.2 Eisai Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eisai Co Ltd SWOT Analysis
2.6.4 Eisai Co Ltd Product and Services
2.6.5 Eisai Co Ltd Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.7 Rodos BioTarget GmbH
2.7.1 Rodos BioTarget GmbH Details
2.7.2 Rodos BioTarget GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Rodos BioTarget GmbH SWOT Analysis
2.7.4 Rodos BioTarget GmbH Product and Services
2.7.5 Rodos BioTarget GmbH Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.8 Integrated BioTherapeutics Inc
2.8.1 Integrated BioTherapeutics Inc Details
2.8.2 Integrated BioTherapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Integrated BioTherapeutics Inc SWOT Analysis
2.8.4 Integrated BioTherapeutics Inc Product and Services
2.8.5 Integrated BioTherapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.9 Fab’entech SA
2.9.1 Fab’entech SA Details
2.9.2 Fab’entech SA Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Fab’entech SA SWOT Analysis
2.9.4 Fab’entech SA Product and Services
2.9.5 Fab’entech SA Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.10 Profectus BioSciences Inc
2.10.1 Profectus BioSciences Inc Details
2.10.2 Profectus BioSciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Profectus BioSciences Inc SWOT Analysis
2.10.4 Profectus BioSciences Inc Product and Services
2.10.5 Profectus BioSciences Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sarepta Therapeutics Inc
2.11.1 Sarepta Therapeutics Inc Details
2.11.2 Sarepta Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sarepta Therapeutics Inc SWOT Analysis
2.11.4 Sarepta Therapeutics Inc Product and Services
2.11.5 Sarepta Therapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
2.12 Theravectys SA
2.12.1 Theravectys SA Details
2.12.2 Theravectys SA Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Theravectys SA SWOT Analysis
2.12.4 Theravectys SA Product and Services
2.12.5 Theravectys SA Marburgvirus Infection Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Marburgvirus Infection Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Marburgvirus Infection Players Market Share
3.2.2 Top 10 Marburgvirus Infection Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Marburgvirus Infection Revenue and Market Share by Regions
4.2 North America Marburgvirus Infection Revenue and Growth Rate (2015-2020)
4.3 Europe Marburgvirus Infection Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Marburgvirus Infection Revenue and Growth Rate (2015-2020)
4.5 South America Marburgvirus Infection Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Marburgvirus Infection Revenue and Growth Rate (2015-2020)
5 North America Marburgvirus Infection Revenue by Countries
5.1 North America Marburgvirus Infection Revenue by Countries (2015-2020)
5.2 USA Marburgvirus Infection Revenue and Growth Rate (2015-2020)
5.3 Canada Marburgvirus Infection Revenue and Growth Rate (2015-2020)
5.4 Mexico Marburgvirus Infection Revenue and Growth Rate (2015-2020)
6 Europe Marburgvirus Infection Revenue by Countries
6.1 Europe Marburgvirus Infection Revenue by Countries (2015-2020)
6.2 Germany Marburgvirus Infection Revenue and Growth Rate (2015-2020)
6.3 UK Marburgvirus Infection Revenue and Growth Rate (2015-2020)
6.4 France Marburgvirus Infection Revenue and Growth Rate (2015-2020)
6.5 Russia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
6.6 Italy Marburgvirus Infection Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Marburgvirus Infection Revenue by Countries
7.1 Asia-Pacific Marburgvirus Infection Revenue by Countries (2015-2020)
7.2 China Marburgvirus Infection Revenue and Growth Rate (2015-2020)
7.3 Japan Marburgvirus Infection Revenue and Growth Rate (2015-2020)
7.4 Korea Marburgvirus Infection Revenue and Growth Rate (2015-2020)
7.5 India Marburgvirus Infection Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
8 South America Marburgvirus Infection Revenue by Countries
8.1 South America Marburgvirus Infection Revenue by Countries (2015-2020)
8.2 Brazil Marburgvirus Infection Revenue and Growth Rate (2015-2020)
8.3 Argentina Marburgvirus Infection Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Marburgvirus Infection by Countries
9.1 Middle East & Africa Marburgvirus Infection Revenue by Countries (2015-2020)
9.2 Saudi Arabia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
9.3 UAE Marburgvirus Infection Revenue and Growth Rate (2015-2020)
9.4 Egypt Marburgvirus Infection Revenue and Growth Rate (2015-2020)
9.5 South Africa Marburgvirus Infection Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Marburgvirus Infection Revenue and Market Share by Type (2015-2020)
10.2 Global Marburgvirus Infection Market Forecast by Type (2019-2024)
10.3 Eritoran Tetrasodium Revenue Growth Rate (2015-2025)
10.4 AR-12 Revenue Growth Rate (2015-2025)
10.5 ARD-5 Revenue Growth Rate (2015-2025)
10.6 AVI-7288 Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Marburgvirus Infection Market Segment by Application
11.1 Global Marburgvirus Infection Revenue Market Share by Application (2015-2020)
11.2 Marburgvirus Infection Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Marburgvirus Infection Market Size Forecast (2021-2025)
12.1 Global Marburgvirus Infection Market Size Forecast (2021-2025)
12.2 Global Marburgvirus Infection Market Forecast by Regions (2021-2025)
12.3 North America Marburgvirus Infection Revenue Market Forecast (2021-2025)
12.4 Europe Marburgvirus Infection Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Marburgvirus Infection Revenue Market Forecast (2021-2025)
12.6 South America Marburgvirus Infection Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Marburgvirus Infection Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Marburgvirus Infection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Marburgvirus Infection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Marburgvirus Infection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Marburgvirus Infection Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Arno Therapeutics Inc Corporate Information, Location and Competitors
Table 6. Arno Therapeutics Inc Marburgvirus Infection Major Business
Table 7. Arno Therapeutics Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 8. Arno Therapeutics Inc SWOT Analysis
Table 9. Arno Therapeutics Inc Marburgvirus Infection Product and Solutions
Table 10. Arno Therapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. NanoViricides Inc Corporate Information, Location and Competitors
Table 12. NanoViricides Inc Marburgvirus Infection Major Business
Table 13. NanoViricides Inc Marburgvirus Infection Total Revenue (USD Million) (2018-2019)
Table 14. NanoViricides Inc SWOT Analysis
Table 15. NanoViricides Inc Marburgvirus Infection Product and Solutions
Table 16. NanoViricides Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Emergent BioSolutions Inc Corporate Information, Location and Competitors
Table 18. Emergent BioSolutions Inc Marburgvirus Infection Major Business
Table 19. Emergent BioSolutions Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 20. Emergent BioSolutions Inc SWOT Analysis
Table 21. Emergent BioSolutions Inc Marburgvirus Infection Product and Solutions
Table 22. Emergent BioSolutions Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioCryst Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 24. BioCryst Pharmaceuticals Inc Marburgvirus Infection Major Business
Table 25. BioCryst Pharmaceuticals Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 26. BioCryst Pharmaceuticals Inc SWOT Analysis
Table 27. BioCryst Pharmaceuticals Inc Marburgvirus Infection Product and Solutions
Table 28. BioCryst Pharmaceuticals Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson & Johnson Corporate Information, Location and Competitors
Table 30. Johnson & Johnson Marburgvirus Infection Major Business
Table 31. Johnson & Johnson Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 32. Johnson & Johnson SWOT Analysis
Table 33. Johnson & Johnson Marburgvirus Infection Product and Solutions
Table 34. Johnson & Johnson Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eisai Co Ltd Corporate Information, Location and Competitors
Table 36. Eisai Co Ltd Marburgvirus Infection Major Business
Table 37. Eisai Co Ltd Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 38. Eisai Co Ltd SWOT Analysis
Table 39. Eisai Co Ltd Marburgvirus Infection Product and Solutions
Table 40. Eisai Co Ltd Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Rodos BioTarget GmbH Corporate Information, Location and Competitors
Table 42. Rodos BioTarget GmbH Marburgvirus Infection Major Business
Table 43. Rodos BioTarget GmbH Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 44. Rodos BioTarget GmbH SWOT Analysis
Table 45. Rodos BioTarget GmbH Marburgvirus Infection Product and Solutions
Table 46. Rodos BioTarget GmbH Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Integrated BioTherapeutics Inc Corporate Information, Location and Competitors
Table 48. Integrated BioTherapeutics Inc Marburgvirus Infection Major Business
Table 49. Integrated BioTherapeutics Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 50. Integrated BioTherapeutics Inc SWOT Analysis
Table 51. Integrated BioTherapeutics Inc Marburgvirus Infection Product and Solutions
Table 52. Integrated BioTherapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Fab'entech SA Corporate Information, Location and Competitors
Table 54. Fab'entech SA Marburgvirus Infection Major Business
Table 55. Fab'entech SA Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 56. Fab'entech SA SWOT Analysis
Table 57. Fab'entech SA Marburgvirus Infection Product and Solutions
Table 58. Fab'entech SA Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Profectus BioSciences Inc Corporate Information, Location and Competitors
Table 60. Profectus BioSciences Inc Marburgvirus Infection Major Business
Table 61. Profectus BioSciences Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 62. Profectus BioSciences Inc SWOT Analysis
Table 63. Profectus BioSciences Inc Marburgvirus Infection Product and Solutions
Table 64. Profectus BioSciences Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sarepta Therapeutics Inc Corporate Information, Location and Competitors
Table 66. Sarepta Therapeutics Inc Marburgvirus Infection Major Business
Table 67. Sarepta Therapeutics Inc Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 68. Sarepta Therapeutics Inc SWOT Analysis
Table 69. Sarepta Therapeutics Inc Marburgvirus Infection Product and Solutions
Table 70. Sarepta Therapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Theravectys SA Corporate Information, Location and Competitors
Table 72. Theravectys SA Marburgvirus Infection Major Business
Table 73. Theravectys SA Marburgvirus Infection Total Revenue (USD Million) (2017-2018)
Table 74. Theravectys SA SWOT Analysis
Table 75. Theravectys SA Marburgvirus Infection Product and Solutions
Table 76. Theravectys SA Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Marburgvirus Infection Revenue (Million USD) by Players (2015-2020)
Table 78. Global Marburgvirus Infection Revenue Share by Players (2015-2020)
Table 79. Global Marburgvirus Infection Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Marburgvirus Infection Revenue Market Share by Regions (2015-2020)
Table 81. North America Marburgvirus Infection Revenue by Countries (2015-2020)
Table 82. North America Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Table 83. Europe Marburgvirus Infection Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Marburgvirus Infection Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Marburgvirus Infection Revenue by Countries (2015-2020)
Table 86. South America Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Marburgvirus Infection Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Table 89. Global Marburgvirus Infection Revenue (Million USD) by Type (2015-2020)
Table 90. Global Marburgvirus Infection Revenue Share by Type (2015-2020)
Table 91. Global Marburgvirus Infection Revenue Forecast by Type (2021-2025)
Table 92. Global Marburgvirus Infection Revenue by Application (2015-2020)
Table 93. Global Marburgvirus Infection Revenue Share by Application (2015-2020)
Table 94. Global Marburgvirus Infection Revenue Forecast by Application (2021-2025)
Table 95. Global Marburgvirus Infection Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Marburgvirus Infection Picture
Figure 2. Global Marburgvirus Infection Revenue Market Share by Type in 2019
Figure 3. Eritoran Tetrasodium Picture
Figure 4. AR-12 Picture
Figure 5. ARD-5 Picture
Figure 6. AVI-7288 Picture
Figure 7. Others Picture
Figure 8. Marburgvirus Infection Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Marburgvirus Infection Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Marburgvirus Infection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Marburgvirus Infection Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Marburgvirus Infection Revenue Market Share in 2019
Figure 21. Global Top 10 Players Marburgvirus Infection Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Marburgvirus Infection Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Marburgvirus Infection Revenue Market Share by Regions (2015-2020)
Figure 25. Global Marburgvirus Infection Revenue Market Share by Regions in 2018
Figure 26. North America Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 27. Europe Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 29. South America Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 31. North America Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Figure 32. North America Marburgvirus Infection Revenue Market Share by Countries in 2019
Figure 33. USA Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 34. Canada Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 36. Europe Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Marburgvirus Infection Revenue Market Share by Countries in 2019
Figure 38. Germany Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 39. UK Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 40. France Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 41. Russia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 42. Italy Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Marburgvirus Infection Revenue Market Share by Countries in 2019
Figure 45. China Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 46. Japan Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 47. Korea Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 48. India Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 50. South America Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Figure 51. South America Marburgvirus Infection Revenue Market Share by Countries in 2019
Figure 52. Brazil Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Marburgvirus Infection Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Marburgvirus Infection Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 57. UAE Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Marburgvirus Infection Revenue and Growth Rate (2015-2020)
Figure 60. Global Marburgvirus Infection Revenue Share by Type (2015-2020)
Figure 61. Global Marburgvirus Infection Revenue Share by Type in 2019
Figure 62. Global Marburgvirus Infection Market Share Forecast by Type (2021-2025)
Figure 63. Global Eritoran Tetrasodium Revenue Growth Rate (2015-2020)
Figure 64. Global AR-12 Revenue Growth Rate (2015-2020)
Figure 65. Global ARD-5 Revenue Growth Rate (2015-2020)
Figure 66. Global AVI-7288 Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Marburgvirus Infection Revenue Share by Application (2015-2020)
Figure 69. Global Marburgvirus Infection Revenue Share by Application in 2019
Figure 70. Global Marburgvirus Infection Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Clinic Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Marburgvirus Infection Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Marburgvirus Infection Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Marburgvirus Infection Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Marburgvirus Infection Revenue Market Forecast (2021-2025)
Figure 78. Europe Marburgvirus Infection Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Marburgvirus Infection Revenue Market Forecast (2021-2025)
Figure 80. South America Marburgvirus Infection Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Marburgvirus Infection Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
院内感染制御感染症の世界市場 2020年 Market Overview The global Healthcare-Acquired Infection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Healthcare-Acqu…- ペプチドベース感染症治療薬の世界市場 2020年 Market Overview The global Peptide Based Infection Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 28730 million by 2025, from USD 23550 million in 2019. The P…
- UV感染制御装置の世界市場 2020年 Market Overview The UV Infection Control Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 院内感染診断の世界市場 2020年 Market Overview The global Hospital-acquired Infection Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…
- 感染対策用品の世界市場 2020年 Market Overview The global Infection Control Supplies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infection Control …